Fortrea Holdings (FTRE) Free Cash Flow (2022 - 2026)
Fortrea Holdings (FTRE) reported Free Cash Flow of -$25.0 million for Q1 2026, up 80.33% on a YoY basis from -$13.9 million in Q1 2025, and down 120.56% quarter-over-quarter from $121.6 million in Q4 2025.
Fortrea Holdings (FTRE) Free Cash Flow (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Free Cash Flow for 5 years, with the latest figure at -$25.0 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 80.33% year-over-year to -$25.0 million; the trailing twelve-month figure through Mar 2026 stood at $190.4 million (up 31.22% YoY), and the FY2025 full-year result was $88.3 million, down 62.79% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$25.0 million, down from $121.6 million in the prior quarter.
- The five-year high for Free Cash Flow was $262.5 million in Q2 2024, with the low at -$127.1 million in Q1 2025.
- Historically, Free Cash Flow has averaged $33.2 million across 5 years, with a median of $9.0 million in 2023.
- The largest YoY upside for Free Cash Flow was 850.0% in 2025 against a maximum downside of 264.18% in 2025.
- Fortrea Holdings' Free Cash Flow stood at $5.1 million in 2022, then soared by 76.47% to $9.0 million in 2023, then jumped by 125.56% to $20.3 million in 2024, then jumped by 499.01% to $121.6 million in 2025, then sank by 120.56% to -$25.0 million in 2026.
- The last three Free Cash Flow figures came in at -$25.0 million (Q1 2026), $121.6 million (Q4 2025), and $79.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | -25.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.00 Mn |
| Mar 31, 2026 | -25.00 Mn |
| Dec 31, 2025 | 121.60 Mn |
| Dec 31, 2025 | 121.60 Mn |
| Sep 30, 2025 | 79.50 Mn |
| Sep 30, 2025 | 79.50 Mn |
| Jun 30, 2025 | 14.30 Mn |
| Jun 30, 2025 | 14.30 Mn |
| Mar 31, 2025 | -127.10 Mn |
| Mar 31, 2025 | -127.10 Mn |
| Dec 31, 2024 | 20.30 Mn |
| Dec 31, 2024 | 20.30 Mn |
| Sep 30, 2024 | -10.60 Mn |
| Sep 30, 2024 | -10.60 Mn |
| Jun 30, 2024 | 262.50 Mn |
| Jun 30, 2024 | 262.50 Mn |
| Mar 31, 2024 | -34.90 Mn |
| Mar 31, 2024 | -34.90 Mn |
| Dec 31, 2023 | 9.00 Mn |
| Dec 31, 2023 | 9.00 Mn |